Nasal dorsal augmentation with freeze-dried allograft bone

Plastic and Reconstructive Surgery

Volumn 124, Issue 4, 2009, Pages 1312-1325

  Clark, Richard P ^a   Wong, Granger ^a   Johnson, Loche M ^a   Hagge, Rosalie J ^a   Ciminello, Frank ^a   Lee, John ^a   Stone, Kiki I ^a   Clark, Isabel A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DICHLORISOPRENALINE; FLUORIDE SODIUM; FLUORINE 18;

ADULT; ARTICLE; BONE ALLOGRAFT; BONE SCINTISCANNING; CEPHALOMETRY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; CORTICAL BONE; FEMALE; FOLLOW UP; FREEZE DRYING; HUMAN; MALE; NOSE RECONSTRUCTION; PRIORITY JOURNAL; TIBIA; VASCULARIZATION;

ADULT; BONE TRANSPLANTATION; FEMALE; FREEZE DRYING; HUMANS; MALE; RHINOPLASTY;

EID: 70349841120     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e3181b5a55b     Document Type: Article

References (54)

1. Mischen BT, Follmar KE, Moyer KE, et al. Metabolic and functional characterization of human adipose-derived stem cells in tissue engineering. Plast Reconstr Surg. 2008;122:725-738.
2. Hollinger JO. Bone Tissue Engineering. Boca Raton: CRC Press; 2005.
3. Jadlowiec JA, Celil AB, Hollinger JO. Bone tissue engineering: Recent advances and promising therapeutic agents. Expert Opin Biol Ther. 2003;3:409-423.
4. Urist MR. Bone: Formation by autoinduction. Science 1965; 150:893-899.
5. Urist MR, Sato K, Brownell AG, et al. Human bone morphogenetic protein (hBMP). Proc Soc Exp Biol Med. 1983;173: 194-199.
6. Garbuz DS, Masri BA, Czitrom AA. Biology of allografting. Orthop Clin North Am. 1998;29:199-204.
7. Czitrom AA. Freeze-dried cortical allografts. Orthopedics 1998; 21:242, 264.
8. Reddi AH. Role of morphogenetic proteins in skeletal tissue engineering and regeneration. Nat Biotechnol. 1998;16:247-252.
9. Joyce MJ. Safety and FDA regulations for musculoskeletal allografts: Perspective of an orthopaedic surgeon. Clin Orthop Relat Res. 2005;435:22-30.
10. McAllister DR, Joyce MJ, Mann BJ, Vangsness CT Jr. Allograft update: The current status of tissue regulation, procurement, processing, and sterilization. Am J Sports Med. 2007; 35:2148-2158.
11. Sarukawa S, Sugawara Y, Harii K. Cephalometric long-term follow-up of nasal augmentation using iliac bone graft. J Craniomaxillofac Surg. 2004;32:233-235.
12. Bilezikian JP, Lawrence RG, Rodan GA, Ott S. Principles of Bone Biology. 2nd ed. Boston: Elsevier; 2002:231-241.
13. Fallon MD. Endocrine Control of Bone and Calcium Metabolism. Amsterdam: Elsevier/North Holland; 1984:144-146.
14. Conrad EU, Ericksen SP, Tencer AF, Strong DM, Mackenzie AE. The effects of freeze-drying and rehydration on cancellous bone. Clin Orthop Rel Res. 1993;290:279-284.
15. Bauer TW, Muschler GF. Bone graft materials: An overview of the basic science. Clin Orthop Rel Res. 2000;371:10-27.
16. Burchardt H. The biology of bone graft repair. Clin Orthop Rel Res. 1983;174:28-42.
17. Schuepbach J, Dassonville O, Poissonnet G, Demard F. Early postoperative bone scintigraphy in the evaluation of microvascular bone grafts in head and neck reconstruction. Head Face Med. 2007;3:20.
18. Soost F, Ivancevic V, Stoll C, Prochno T. 3-phase bone scintigraphy of microsurgically attached bone transplants as early graft survival assessment (in German). Handchir Mikrochir Plast Chir. 1999;31:42-46.
19. Moskowitz GW, Lukash F. Evaluation of bone graft viability. Semin Nucl Med. 1988;18:246-254.
20. Ramsay SC, Yeates MG, Ho LC. Bone scanning in the early assessment of nasal bone graft viability. J Nucl Med. 1991;32: 33-36.
21. Fukuta K, Har-Shai Y, Collares MV, Herschman BR, Persiani RJ, Jackson IT. The viability of revascularized calvarial bone graft in a pig model. Ann Plast Surg. 1992;29:136-142.
22. Watkinson JC. Nuclear medicine in otolaryngology. Clin Otolaryngol Allied Sci. 1990;15:457-469.
23. Fig LM, Shulkin BL, Sullivan MJ, Rubinstein MI, Baker SR. Utility of emission tomography in evaluation of mandibular bone grafts. Arch Otolaryngol Head Neck Surg. 1990;116:191-196.
24. Even-Sapir E, Metser U, Mishani E, Lievshitz G, Lerman H, Liebovitch I. The detection of bone metastases in patients with high-risk prostate cancer: 99mTcMDP planar bone scintigraphy, single-and multi-field-of-view SPECT, 18Ffluoride PET, and 18F-fluoride PET/CT. J Nucl Med. 2006;47:287-297.
25. Langsteger W, Heinisch M, Fogelman I. The role of fluorodeoxyglucose, 18F-dihydroxyphenylalanine, 18F-choline, and 18F-fluoride in bone imaging with emphasis on prostate and breast. Semin Nucl Med. 2006;36:73-92.
26. Hetzel M, Arslandemir C, Konig HH, et al. F-18 NaF PET for detection of bone metastases in lung cancer: Accuracy, costeffectiveness, and impact on patient management. J Bone Miner Res. 2003;18:2206-2214.
27. Bares R. Skeletal scintigraphy in breast cancer management. Q J Nucl Med. 1998;42:43-48.
28. Schirrmeister H, Guhlmann A, Elsner K, et al. Sensitivity in detecting osseous lesions depends on anatomic localization: Planar bone scintigraphy versus 18F PET. J Nucl Med. 1999; 40:1623-1629.
29. Krishnamurthty GT, Huebotter RJ, Tubis M, Blahd WH. Pharmacokinetics of current skeletal-seeking radiopharmaceuticals. AJR Am J Roentgenol. 1976;126:293-301.
30. Moon NF, Dworkin HJ, LaFluer PD. The clinical use of sodium fluoride F 18 in bone photoscanning. JAMA. 1968; 204:974-980.
31. Hagge RJ, Clark RP, Badawi RD, Shelton DK. Assessment of incorporation of human cadaveric bone allografts in augmentation rhinoplasty, using F-18 NaF PET/CT. J Nucl Med. 2008;49(Suppl 1):267P.
32. Berding G, Burchert W, van den Hoff J, et al. Evaluation of the incorporation of bone grafts used in maxillofacial surgery with [18F] fluoride ion and dynamic positron emission tomography. Eur J Nucl Med. 1995;22:1133-1140.
33. Berding G, Schliephake H, van den Hoff J, Knapp WH. Assessment of the incorporation of revascularized fibula grafts used for mandibular reconstruction with F-18 PET. Nuklearmedizin 2001;40:51-58.
34. Dasa V, Adbel-Nabi H, Anders MJ, Mihalko WM. F-18 fluoride positron emission tomography of the hip for osteonecrosis. Clin Orthop Relat Res. 2008;466:1081-1086.
35. Palmedo H, Grohe C, Ko Y, Tasci S. PET and PET/CT with F-18 fluoride in bone metastases. Recent Results Cancer Res. 2008;170:213-224.
36. Urist MR. Bone: Formation by autoinduction. 1965. Clin Orthop Relat Res. 2002;395:4-10.
37. Tomford WW. Transmission of disease through transplantation of musculoskeletal allografts. J Bone Joint Surg (Am.) 1995;77:1742-1754.
38. Buck BE, Malinin TI. Human bone and tissue allografts: Preparation and safety. Clin Orthop Relat Res. 1994;303: 8-17.
39. Boyce T, Edwards J, Scarborough N. Allograft bone: The influence of processing on safety and performance. Orthop Clin North Am. 1999;30:571-581.
40. Marx RE, Kline SN, Johnson RP, Malinin TI, Matthews JG II, Gambill VJ. The use of freeze-dried allogeneic bone in oral and maxillofacial surgery. J Oral Surg. 1981;39:264-274.
41. Kelly JF, Friedlaender GE. Prosthetic bone graft augmentation with allogeneic bone: Apreliminary report. J Oral Surg. 1977;35:268-275.
42. Hubli EH, Salyer KE, Gendler E. Demineralized bone bandeau in a patient with kleeblattschadel skull deformity. Ann Plast Surg. 1998;41:81-85.
43. Yavuzer R, Tuncer S, Başterzi Y, Işik I, Sari A, Latifoglu O. Reconstruction of orbital floor fracture using solvent-preserved bone graft. Plast Reconstr Surg. 2004;113:34-44.
44. Vargel I, Tuncbilek G, Mavili E, et al. Solvent-dehydrated calvarial allografts in craniofacial surgery. Plast Reconstr Surg. 2004;114:298-306.
45. Flemming JE, Cornell C, Muschler G. Bone cells and matrices in orthopedic tissue engineering. Orthop Clin North Am. 2000; 31:357-374.
46. Redondo LM, Verrier Hernandez A, Garcia Cantera JM, Torres Nieto MA, Vaquera Puerta C. Repair of experimental mandibular defects in rats with autogenous, demineralised, frozen and fresh bone. Br J Oral Maxillofac Surg. 1997;35: 166-169.
47. Salyer KE. Personal communication. 2006.
48. Canale ST, Beaty J. Campbell's Operative Orthopedics. St. Louis: Elsevier; 2007.
49. Drosos GI, Kazakos KI, Kouzoumpasis P, Verettas DA. Safety and efficacy of commercially available demineralized bone matrix preparations: A critical review of clinical studies. Injury 2007;Suppl 4:S13-S21.
50. Chapman MW. Chapman's Orthopaedic Surgery. Philadelphia: Lippincott Williams & Wilkins; 2001.
51. Head WC, Malinin TI, Mallory TH, Emerson RH Jr. Onlay cortical allografting for the femur. Orthop Clin North Am. 1998;29:307-312.
52. Wolfe A. Personal communication, 2007.
53. Reddy H. Personal communication, 2005.
54. Aspenberg P, Astrand J. Bone allografts pretreated with a bisphosphonate are not resorbed. Acta Orthop Scand. 2002; 73:20-23.